1187966-93-3
Pitavastatin Impurity 2
CAS: 1187966-93-3
Molecular Formula: C25H22FNO4
1187966-93-3 - Names and Identifiers
1187966-93-3 - Physico-chemical Properties
| Molecular Formula | C25H22FNO4 |
| Molar Mass | 419.45 |
| Density | 1.444±0.06 g/cm3(Predicted) |
| Boling Point | 752.0±60.0 °C(Predicted) |
| Solubility | Methanol (Slightly) |
| Appearance | Solid |
| Color | Pale Beige to Light Beige |
| pKa | 4.23±0.10(Predicted) |
| Storage Condition | Hygroscopic, -20°C Freezer, Under inert atmosphere |
| Stability | Hygroscopic |
1187966-93-3 - Introduction
Pitavastatin is a commonly used lipid-lowering drug, also known as a statin. Pitavastatin Impurity 2 is a by-product or Impurity of Pitavastatin. The following is a description of the nature, use, formulation and safety information of Pitavastatin Impurity 2:
Nature:
Pitavastatin Impurity 2 is usually a solid substance whose chemical structure is somewhat different from that of Pitavastatin. It may be a colorless or yellowish crystal that is relatively stable at room temperature.
Use:
Pitavastatin Impurity 2 is a by-product of the Pitavastatin pharmaceutical process and is not a compound intended for use as a drug. Pitavastatin Impurity 2 is generally considered to be an inactive or less active substance that has no direct effect on the efficacy of lipid-lowering drugs.
Preparation Method:
Pitavastatin Impurity 2 is formed during the production of Pitavastatin, and is usually produced by the simultaneous reaction of Pitavastatin precursor compounds with other reactants.
Safety Information:
Nature:
Pitavastatin Impurity 2 is usually a solid substance whose chemical structure is somewhat different from that of Pitavastatin. It may be a colorless or yellowish crystal that is relatively stable at room temperature.
Use:
Pitavastatin Impurity 2 is a by-product of the Pitavastatin pharmaceutical process and is not a compound intended for use as a drug. Pitavastatin Impurity 2 is generally considered to be an inactive or less active substance that has no direct effect on the efficacy of lipid-lowering drugs.
Preparation Method:
Pitavastatin Impurity 2 is formed during the production of Pitavastatin, and is usually produced by the simultaneous reaction of Pitavastatin precursor compounds with other reactants.
Safety Information:
Last Update：2024-04-09 01:59:58
